U.S. FDA grants emergency use authorization to Regeneron COVID-19 antibody given to Trump | Reuters(Reuters)
The U.S. Food and Drug Administration on Saturday issued an emergency use authorization for Regeneron Pharmaceuticals Inc’s COVID-19 antibody therapy, an experimental treatment given to U.S. President Donald Trump that he said helped cure him of the disease.#HealthForAll#HealthBroadcastingService#GlobalHealth#Covid-19#Health#HealthBroadcastingServiceInPublicHealthPartnershiphttps://www.reuters.com/…/us-health-coronavirus…
